BRPI0914768A2 - composições farmacêuticas que compreendem um complexo de derivados de aminociclohexano e ciclodextrina - Google Patents
composições farmacêuticas que compreendem um complexo de derivados de aminociclohexano e ciclodextrinaInfo
- Publication number
- BRPI0914768A2 BRPI0914768A2 BRPI0914768A BRPI0914768A BRPI0914768A2 BR PI0914768 A2 BRPI0914768 A2 BR PI0914768A2 BR PI0914768 A BRPI0914768 A BR PI0914768A BR PI0914768 A BRPI0914768 A BR PI0914768A BR PI0914768 A2 BRPI0914768 A2 BR PI0914768A2
- Authority
- BR
- Brazil
- Prior art keywords
- aminocyclohexane
- complex
- pharmaceutical compositions
- cyclodextrin derivatives
- cyclodextrin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13316208P | 2008-06-26 | 2008-06-26 | |
| EP08011633 | 2008-06-26 | ||
| PCT/EP2009/004599 WO2009156160A1 (en) | 2008-06-26 | 2009-06-25 | Pharmaceutical compositions comprising a complex of aminocyclohexane derivatives and cyclodextrin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0914768A2 true BRPI0914768A2 (pt) | 2015-10-20 |
Family
ID=40042958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0914768A BRPI0914768A2 (pt) | 2008-06-26 | 2009-06-25 | composições farmacêuticas que compreendem um complexo de derivados de aminociclohexano e ciclodextrina |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110092600A1 (pt) |
| EP (1) | EP2310053A1 (pt) |
| JP (1) | JP2011525513A (pt) |
| KR (1) | KR20110015445A (pt) |
| CN (1) | CN102046204A (pt) |
| AR (1) | AR072380A1 (pt) |
| AU (1) | AU2009262490A1 (pt) |
| BR (1) | BRPI0914768A2 (pt) |
| CA (1) | CA2722147A1 (pt) |
| IL (1) | IL210163A0 (pt) |
| MX (1) | MX2010013451A (pt) |
| RU (1) | RU2011102784A (pt) |
| TW (1) | TW201006463A (pt) |
| WO (1) | WO2009156160A1 (pt) |
| ZA (1) | ZA201008242B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2548552B1 (en) * | 2007-09-12 | 2015-11-18 | Merz Pharma GmbH & Co. KGaA | Titration package for 1-amino-alkylcyclohexanes |
| US20110294890A1 (en) * | 2010-05-28 | 2011-12-01 | Merz Pharma Gmbh & Co. Kgaa | Neramexane for the treatment or prevention of inner ear disorders |
| RU2013102263A (ru) * | 2010-06-18 | 2014-07-27 | Мерц Фарма Гмбх Унд Ко. Кгаа | Гелевые лекарственные формы для местного применения производных 1-аминоалкилциклогексана |
| BR112013001609A2 (pt) | 2010-07-22 | 2017-04-04 | Merz Pharma Gmbh & Co Kgaa | composição farmacêutica, processo para a preparação de uma composição farmacêutica, e, uso de um composto de ciclodextrina |
| WO2013087808A1 (en) | 2011-12-15 | 2013-06-20 | Merz Pharma Gmbh & Co. Kgaa | Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin |
| FR3014694B1 (fr) * | 2013-12-13 | 2016-11-11 | Roquette Freres | Compositions a base de methyl-cyclodextrines pour le traitement et/ou la prevention de maladies par augmentation du taux de cholesterol-hdl |
| DE102017004149A1 (de) | 2017-05-02 | 2018-11-08 | Azur Space Solar Power Gmbh | Lichtempfangseinheit |
| US20230226100A1 (en) * | 2020-05-01 | 2023-07-20 | University Of Southern California | Cyclodextrin based anti-microbial therapy |
| CN114886945B (zh) * | 2022-05-10 | 2023-07-07 | 西安外事学院 | 一种调节嘌呤代谢的超分子药物及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1237128B (it) * | 1989-11-10 | 1993-05-18 | Magis Farmaceutici | Composti ad attivita' espettorante ottenuti per complessazione del trans-4-(2-ammino-3,5-dibromo-benzilammino)cicloesanolo con una ciclodestrina, loro preparazione e loro utilizzazione |
| KR100630506B1 (ko) * | 1997-06-30 | 2006-09-29 | 메르츠 파마 게엠베하 운트 코. 카가아 | Ｎｍｄａ 수용체 길항물질로서의 1-아미노-알킬시클로헥산 화합물, 이를 함유하는 제약학적 조성물 및 이것으로 치료하는 방법 |
| AR046314A1 (es) * | 2003-11-05 | 2005-11-30 | Merz Pharma Gmbh & Co Kgaa | Composiciones que comprenden ciclohexilaminas y aminoadamantanos |
| ES2564187T3 (es) * | 2005-04-05 | 2016-03-18 | Yale University | Agentes de modulación de glutamato en el tratamiento de trastornos mentales |
| US20070141148A1 (en) * | 2005-11-30 | 2007-06-21 | Merz Pharma Gmbh & Co. Kgaa | Neramexane MR matrix tablet |
| EP2040676A2 (en) * | 2006-07-06 | 2009-04-01 | Forest Laboratories, Inc. | Orally dissolving formulations of memantine |
-
2009
- 2009-06-23 TW TW098121003A patent/TW201006463A/zh unknown
- 2009-06-25 MX MX2010013451A patent/MX2010013451A/es unknown
- 2009-06-25 BR BRPI0914768A patent/BRPI0914768A2/pt not_active IP Right Cessation
- 2009-06-25 RU RU2011102784/15A patent/RU2011102784A/ru not_active Application Discontinuation
- 2009-06-25 EP EP09769009A patent/EP2310053A1/en not_active Withdrawn
- 2009-06-25 JP JP2011515209A patent/JP2011525513A/ja not_active Withdrawn
- 2009-06-25 CA CA2722147A patent/CA2722147A1/en not_active Abandoned
- 2009-06-25 CN CN2009801189573A patent/CN102046204A/zh active Pending
- 2009-06-25 KR KR1020107029071A patent/KR20110015445A/ko not_active Ceased
- 2009-06-25 AU AU2009262490A patent/AU2009262490A1/en not_active Abandoned
- 2009-06-25 WO PCT/EP2009/004599 patent/WO2009156160A1/en not_active Ceased
- 2009-06-25 US US12/737,283 patent/US20110092600A1/en not_active Abandoned
- 2009-06-26 AR ARP090102384A patent/AR072380A1/es not_active Application Discontinuation
-
2010
- 2010-11-17 ZA ZA2010/08242A patent/ZA201008242B/en unknown
- 2010-12-21 IL IL210163A patent/IL210163A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR072380A1 (es) | 2010-08-25 |
| MX2010013451A (es) | 2011-03-21 |
| JP2011525513A (ja) | 2011-09-22 |
| IL210163A0 (en) | 2011-03-31 |
| KR20110015445A (ko) | 2011-02-15 |
| AU2009262490A1 (en) | 2009-12-30 |
| WO2009156160A1 (en) | 2009-12-30 |
| ZA201008242B (en) | 2011-07-27 |
| US20110092600A1 (en) | 2011-04-21 |
| CA2722147A1 (en) | 2009-12-30 |
| CN102046204A (zh) | 2011-05-04 |
| TW201006463A (en) | 2010-02-16 |
| RU2011102784A (ru) | 2012-08-10 |
| EP2310053A1 (en) | 2011-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0914768A2 (pt) | composições farmacêuticas que compreendem um complexo de derivados de aminociclohexano e ciclodextrina | |
| BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
| BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
| EP2240022A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EP2265283A4 (en) | Auristatin-DRUG-LINKER CONJUGATES | |
| EP2167043A4 (en) | NEW USE CO-CRYSTAL COMPOSITIONS | |
| EP2373681A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| BRPI1012201A2 (pt) | composto anticacerígeno e composição farmacêutica que o contém | |
| ES2465478T8 (es) | Composiciones farmacéuticas que comprenden brivaracetam | |
| PT2252628T (pt) | Conjugados antagonistas de péptidos análogos de bombesina | |
| EP2456310A4 (en) | SUBSTITUTED BENZOIMIDAZOLSULFONAMIDES AND SUBSTITUTED INDOLSULFONAMIDES AS MGLUR4 POTENTIATORS | |
| BRPI0923836A2 (pt) | Composições farmacêuticas orais contendo opióide e métodos | |
| EP2451274A4 (en) | Pharmaceutical compositions | |
| EP2419097A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| ES2784629T8 (es) | Composiciones farmacéuticas inyectables estables que comprenden 2-hidroxipropil-beta-ciclodextrina y alfaxalona | |
| LT2966175T (lt) | Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| EP2124556A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| IL206594A (en) | The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| EP2154966A4 (en) | BENZIMIDAZOLE AND PHARMACEUTICAL COMPOSITIONS FROM THEREOF | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| BRPI0917661A2 (pt) | produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan | |
| DK2391351T3 (da) | Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater | |
| BR112013012313A2 (pt) | combinação farmacêutica de paclitaxel e um inibidor de cdk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 9/08 (2006.01), A61K 31/13 (2006.01), A61K 47 |